You are here

Albert Labs International Corp.

Albert Labs Logo
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
ABRT
CSE Index: 
Currency: 

Albert Labs International Corp. is a research and drug development company addressing mental health care needs. Through a succinct clinical pathway, focusing on Real World Evidence (RWE) Albert Labs look to commercialize its psychedelic-based treatments, and in doing so deliver psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access and faster approvals, Albert Labs put patients with urgent and unmet needs first as it develops licensed medicines to treat a variety of mental health conditions. Cancer-related distress, an initial focus of Albert Labs development program is thought to affect over 16 million patients worldwide.

You are here

Albert Labs International Corp. (ABRT)

SEDAR Information

Company Info

Address
#201 - 6996 Merritt Avenue
Burnaby, BC V5J 4R6
Canada
Phone
(778) 819 0740
Email
[email protected]
Website
https://www.albertlabs.com
Listing date
Tuesday, September 6, 2011
Transfer Agent
Computershare Investor Services Inc.

Capitalization

Issued & Outstanding: 
74413267
Reserved for Issuance: 
11985000

News Releases

Bulletins

07/07/2023

2023-0707 - Reinstatement – Albert Labs International Corp. (ABRT)

le 7 juillet/July 2023

Effective immediately, Albert Labs International Corp. will be reinstated for trading.

The Company has rectified the situation that gave rise to the suspension.

____________________________